Robuta

https://www.cochrane.org/zh-hant/evidence/CD000480_vinpocetine-acute-ischaemic-stroke Vinpocetine for acute ischaemic stroke | Cochrane acute ischaemic strokevinpocetinecochrane https://www.nice.org.uk/guidance/ta264/chapter/2-The-technology 2 The technology | Alteplase for treating acute ischaemic stroke | Guidance | NICE Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults acute ischaemic strokethe technologyalteplase https://www.cochrane.org/evidence/CD000029_oral-antiplatelet-therapy-acute-ischaemic-stroke Oral antiplatelet therapy for acute ischaemic stroke | Cochrane acute ischaemic strokeoraltherapycochrane https://www.longdom.org/open-access/acute-ischaemic-stroke-treated-with-intravenous-thrombolysis-in-a-patient-with-a-known-large-brainstem-cavernous-malform-48962.html Acute Ischaemic Stroke Treated with Intravenous Thrombolysis in a Longdom Publishing SL is one of the leading international open access journals publishers, covering clinical, medical, and technology-oriented subjects acute ischaemic stroketreatedintravenousthrombolysis https://www.nice.org.uk/guidance/ta264/history History | Alteplase for treating acute ischaemic stroke | Guidance | NICE Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults acute ischaemic strokehistoryalteplasetreatingguidance https://www.cochrane.org/zh-hans/evidence/CD003242_anticoagulants-versus-antiplatelet-agents-acute-ischaemic-stroke Anticoagulants versus antiplatelet agents for acute ischaemic stroke | Cochrane acute ischaemic strokeantiplatelet agentsanticoagulantsversuscochrane https://www.cochrane.org/evidence/CD002087_tirilazad-acute-ischaemic-stroke Tirilazad for acute ischaemic stroke | Cochrane acute ischaemic strokecochrane https://www.cochrane.org/hr/evidence/CD003435_surgical-decompression-cerebral-oedema-acute-ischaemic-stroke Surgical decompression for cerebral oedema in acute ischaemic stroke | Cochrane acute ischaemic strokesurgicaldecompressioncerebraloedema https://pmc.ncbi.nlm.nih.gov/articles/PMC3721925/ Management of ischaemic stroke in the acute setting: review of the current status - PMC Acute ischaemic stroke can be treated by clot busting and clot removal. Thrombolysis using intravenous recombinant-tissue plasminogen activator (IV r-TPA) is... ischaemic strokein the https://www.cochrane.org/ru/evidence/CD004955_puerarin-acute-ischaemic-stroke Puerarin for acute ischaemic stroke | Cochrane acute ischaemic strokecochrane https://www.cochrane.org/evidence/CD000064_corticosteroids-acute-ischaemic-stroke Corticosteroids for acute ischaemic stroke | Cochrane acute ischaemic strokecorticosteroidscochrane https://www.gov.uk/government/publications/alteplase-for-treatment-of-acute-ischaemic-stroke-independent-review Alteplase for treatment of acute ischaemic stroke: independent review - GOV.UK The review of alteplase in the treatment of acute ischaemic stroke by the expert working group of the Commission on Human Medicines. acute ischaemic strokeindependent reviewalteplasetreatment https://www.nice.org.uk/guidance/ta264/resources Tools and resources | Alteplase for treating acute ischaemic stroke | Guidance | NICE Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults tools and resourcesacute ischaemic strokealteplase https://www.santepubliquefrance.fr/maladies-cardiovasculaires-et-accident-vasculaire-cerebral/accident-vasculaire-cerebral/article/effectiveness-antihypertensive-drugs-secondary-prevention-ischaemic-stroke-a-nationwide-historic Effectiveness of antihypertensive drugs for secondary prevention of ischaemic stroke: a nationwide... antihypertensive drugssecondary preventionischaemic strokeeffectiveness https://www.cochrane.org/ru/evidence/CD000211_theophylline-aminophylline-caffeine-and-analogues-acute-ischaemic-stroke Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke | Cochrane acute ischaemic stroketheophyllineaminophyllinecaffeinecochrane https://pmc.ncbi.nlm.nih.gov/articles/PMC8370080/ European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack - PMC The aim of the present European Stroke Organisation Transient Ischaemic Attack (TIA) management guideline document is to provide clinically useful... https://www.nice.org.uk/guidance/ta264/chapter/8-Sources-of-evidence-considered-by-the-Committee 8 Sources of evidence considered by the Committee | Alteplase for treating acute ischaemic stroke |... Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults https://www.nice.org.uk/guidance/ta264/chapter/4-Consideration-of-the-evidence 4 Consideration of the evidence | Alteplase for treating acute ischaemic stroke | Guidance | NICE Evidence-based recommendations on alteplase (Actilyse) for treating acute ischaemic stroke in adults https://pmc.ncbi.nlm.nih.gov/articles/PMC7377582/ The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a... To investigate the associations between major foods and dietary fibre with subtypes of stroke in a large prospective cohort. We analysed data on 418 329 men... https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2016/05/12/22/30/SOCRATES Acute Stroke or Transient Ischaemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes... Dharam J. Kumbhani, MD, SM, FACC https://www.sciencemediacentre.org/expert-reaction-to-study-looking-at-covid-19-ischaemic-stroke-and-blood-clots/ expert reaction to study looking at COVID-19, ischaemic stroke and blood clots | Science Media... https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.663899/full Frontiers | Prediction of Clinical Outcomes in Acute Ischaemic Stroke Patients: A Comparative Study Clinical stroke rehabilitation decision-making relies on multi-modal data, including imaging and other clinical assessments. However, most previously describ... acute ischaemic stroke https://www.mja.com.au/journal/2004/180/3/tissue-plasminogen-activator-tpa-acute-ischaemic-stroke-why-so-much-has-been-0 Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so... Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little https://www.elan-trial.ch/ ELAN Trial | Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke... https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1533674/full Frontiers | New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke... Background and purposeThe objective of this study is to systematically review the efficacy and safety of cilostazol-based dual antiplatelet therapy (DAPT) in... new optionsfrontierscilostazol https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2012/01/25/16/35/Evaluation-of-Risk-Stratification-Schemes-for-Ischaemic-Stroke Evaluation of Risk Stratification Schemes for Ischaemic Stroke and Bleeding in 182,678 Patients... https://hku.hk/press/news_detail_27315.html HKUMed study finds good clinical outcomes for over 30% of ischaemic stroke patients receiving... HKUMed research team finds that over 30% of ischaemic stroke patients who received intra-arterial mechanical thrombectomy had a good clinical outcome even... https://openreview.net/forum?id=SyeOMoR4q4 Significance of Residual Learning and Boundary Weighted Loss in Ischaemic Stroke Lesion... Residual learning with adversarial training and boundary weighted loss function results in significant boost in performance of ischaemic stroke segmentation. https://www.rug.nl/about-ug/latest-news/news/archief2013/promoties-oraties/promotie-dhr.-m.m.h.-lahr_-organisational-models-for-thrombolysis-in-acute-ischaemic-stroke.-a-s PhD ceremony Mr. M.M.H. Lahr: Organisational models for thrombolysis in acute ischaemic stroke. A... Sep 14, 2021 - PhD ceremony: Mr. M.M.H. Lahr Dissertation: Organisational models for thrombolysis in acute ischaemic stroke. A simulation exemplar Promotor(s): prof. E... https://scirp.org/journal/paperinformation?paperid=113585 Serum Ferritin and D-Dimer as Possible Risk Factors in Ischaemic Stroke in Cancer Patients Discover the impact of cancer on ischemic stroke with this study comparing serum ferritin and d-dimer levels. Findings reveal a significant rise in... https://pmc.ncbi.nlm.nih.gov/articles/PMC10472963/ Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020 - PMC We assessed best available data on access and delivery of acute stroke unit (SU) care, intravenous thrombolysis (IVT) and endovascular treatment (EVT) in the... https://www.elsevier.es/en-revista-neurologia-english-edition--495-articulo-use-emergency-medical-transport-impact-S2173580818301664 Use of emergency medical transport and impact on time to care in patients with ischaemic stroke |... IntroductionAccording to numerous studies, using emergency medical services (EMS) to https://www.mdpi.com/1660-4601/19/21/13848 Life and Leisure Activities following Stroke or Transient Ischaemic Attack (TIA): An Observational,... Objective: To examine changes in leisure participation following stroke/transient ischaemic attack (TIA) and explore its relationship to modifiable and... life and leisure